Furthermore, recent studies suggested that some extracellular heat shock proteins could be used as therapeutic targets and biomarkers in fibrosing interstitial lung diseases [70], which also brings a new direction to future studies of HSP22. The gene discussed is HSPB8; the disease is interstitial lung disease.